eFFECTOR Therapeutics's total assets for Q1 2024 were $27.13M, an increase of 34.57% from the previous quarter. EFTR total liabilities were $26.30M for the fiscal quarter, a 9.02% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.